Seeing double: Designing drugs that target ‘twin’ cancer proteins

Some proteins in the human body are easy to block with a drug; they have an obvious spot in their structure where a drug can fit, like a key in a lock. But other proteins are more difficult to target, with no clear drug-binding sites.

Click here to view the original article.